Page last updated: 2024-08-21

thiazoles and Gout

thiazoles has been researched along with Gout in 145 studies

Research

Studies (145)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (1.38)	18.7374
1990's	2 (1.38)	18.2507
2000's	38 (26.21)	29.6817
2010's	99 (68.28)	24.3611
2020's	4 (2.76)	2.80

Authors

Authors	Studies
Calogiuri, G; Congedo, M; Foti, C; Macchia, L; Nettism, E; Vacca, A	1
Becker, MA; Borer, JS; Castillo, M; Gorelick, PB; Gunawardhana, L; Hunt, B; Saag, KG; Whelton, A; White, WB	1
Jatuworapruk, K; Lertnawapan, R	1
Borghi, C; Desideri, G; Gerritsen, M; Giannattasio, C; Nurmohamed, MT; Rajzer, M; Tausche, AK	1
Gunawardhana, L; White, WB	1
Bhattacharyya, S; Macklin, EA; Schwarzschild, MA	1
Bartsch, LA; Ortiz, A; Perez-Gomez, MV	1
Lundberg, JO; Montenegro, MF; Weitzberg, E	1
Bianchi, G; Borghi, C; Bortoluzzi, A; Cimmino, MA; D'Avola, GM; Desideri, G; Di Giacinto, G; Favero, M; Govoni, M; Grassi, W; Lombardi, A; Manara, M; Marangella, M; Matucci Cerinic, M; Medea, G; Minisola, G; Prevete, I; Punzi, L; Ramonda, R; Scirè, CA; Spadaro, A	1
Becker, MA; Hunt, BJ; Jackson, RL; MacDonald, PA	1
Beard, SM; Nuki, G; Pearson, IV; von Scheele, BG	1
Franklin, JM; Kim, SC; Liu, J; Schmidt, BM; Schneeweiss, S; Solomon, DH	1
Aringer, M; Bielitz, C; Christoph, M; Forkmann, M; Kopprasch, S; Richter, U; Tausche, AK; Wunderlich, C	1
Dhakad, U; Dhaon, P; Wakhlu, A	1
Bakris, GL; Doghramji, PP; Keenan, RT; Silber, SH	1
Ehteshami-Afshar, A; Faruque, LI; Homik, J; Tjosvold, L; Tonelli, M; Wiebe, N	1
Stamp, LK	1
Bao, C; Du, H; Gu, J; Huang, A; Huang, X; Jiang, L; Li, J; Li, X; Li, Z; Liu, Y; Zhang, Y; Zhang, Z; Zhao, D; Zhu, P; Zuo, X	1
Baumgartner, S; Fleischmann, R; Hingorani, V; Kerr, B; Manhard, K; Miner, JN; Polvent, E; Quart, B; Shen, Z; Suster, M; Yeh, LT	1
Bae, EJ; Chang, SH; Cho, HS; Jang, HN; Kang, Y; Kim, MJ; Park, DJ; Yun, S	1
Singh, JA	3
Akhras, KS; Hatoum, H; Khanna, D; Khanna, P; Lin, SJ; Shiozawa, A	1
Bocale, R; Desideri, G; Ferri, C; Grassi, D; Pontremoli, R	1
Becker, MA; Chaichian, Y; Chohan, S	1
Edwards, NL; So, A	1
Banse, C; Fardellone, P; Paccou, J	1
Jansen, TL	1
Joo, H; Joo, K; Jung, KH; Kwon, SR; Lim, MJ; Park, W	1
Mounsey, A; Tillett, J; White, S	1
Kim, HA; Seo, YI; Song, YW	1
Hayashi, H; Hayashi, T; Hikosaka, S; Mizuno, T; Murase, M; Nagamatsu, T; Shimabukuro, Y; Takahashi, K; Yamada, S; Yuzawa, Y	1
Abdi-Ali, L; Benucci, M; Cera, I; Rossini, M; Sacco, S; Saviola, G	1
Bombardier, C; Buchbinder, R; Edwards, CJ; Kydd, AS; Seth, R	1
Choi, HK; Jutkowitz, E; Kuntz, KM; Pizzi, LT	1
Dalbeth, N; Robinson, PC	1
Bridgeman, MB; Chavez, B	1
Bottorff, MB; Gandhi, PK; Gentry, WM; Ma, Q	1
Flipo, RN; Patrikos, DK; Richette, P	1
Li, L; Lu, W; Sun, Y; Zhou, TY	1
Fujimaki, K; Fujisaki, T; Gemba, K; Goto, T; Kaneko, M; Kawai, Y; Kiguchi, T; Kirito, K; Maemondo, M; Nakajima, A; Okamoto, M; Takeda, K; Tamura, K; Ueda, T	1
Bakinde, N; Mome, R	1
Filiopoulos, V; Hadjiyannakos, D; Vlassopoulos, D	1
Sircar, D	1
Andrés, M; Gil, S; Pascual, E; Quilis, N; Ranieri, L; Vela, P	1
Becker, MA; Hunt, BJ; Joseph-Ridge, N; Lademacher, C; MacDonald, PA	1
Chen, LX; Schumacher, HR	1
Hair, PI; Keating, GM; McCormack, PL	1
Schlesinger, N	2
Edwards, NL	2
Sundy, JS	2
Becker, MA; Hunt, B; Joseph-Ridge, N; Lademacher, C; Macdonald, PA; Schumacher, HR; Streit, J; Wortmann, RL	1
Yu, KH	1
Becker, MA; Lademacher, C; Lloyd, E; MacDonald, PA; Schumacher, HR	2
Traynor, K	1
Becker, MA; Chohan, S	1
Keenan, RT; Pillinger, MH	1
Lioté, F; Perez-Ruiz, F; Scavulli, J; Terkeltaub, R; Zelman, D	1
Pandor, A; Stevenson, M	2
Ernst, ME; Fravel, MA	1
Belavic, JM	1
Jansen, TL; Reinders, MK	1
Becker, MA; Espinoza, LR; Lademacher, C; Lloyd, E; MacDonald, P; Schumacher, HR; Wells, AF	1
Bardin, T; Barskova, V; Doherty, M; Guerne, PA; Jansen, TL; Leeb, B; Pascual, E; Perez-Ruiz, F; Pimentão, J; Punzi, L; Richette, P; Tausche, AK; Uhlig, T; Zimmermann-Górska, I	1
Barrons, R; Love, BL; Snider, KM; Veverka, A	1
Julkunen, H; Konttinen, YT	1
Burns, CM; Wortmann, RL	1
Quillen, DM	1
Graser, E; Pope, RS; Zychowicz, ME	1
El-Zawawy, H; Mandell, BF	1
Gunawardhana, L; Hunt, B; Macdonald, PA; Whelton, A; Zhao, L	1
Stiefelhagen, P	1
Cohen, MG	1
Gray, CL; Walters-Smith, NE	1
Hunt, B; Jackson, RL; Macdonald, PA; Wortmann, RL	1
Dubost, JJ; Mathieu, S; Soubrier, M	1
Doghramji, PP	1
Goldfarb, DS; Gunawardhana, L; Hunt, B; MacDonald, PA	1
El-Armouche, A; Emons, J; Wittköpper, K	1
Reid, G; Uh, M	1
Hosoya, T; Kamatani, N; Naoyuki, K; Tatsuo, H	1
Fujimori, S; Hada, T; Hosoya, T; Kamatani, N; Kohri, K; Matsuzawa, Y; Nakamura, T; Ueda, T; Yamamoto, T; Yamanaka, H	2
Fujimori, S; Hada, T; Hisashi, Y; Hosoya, T; Kamatani, N; Kenjiro, K; Kohri, K; Matsuzawa, Y; Nakamura, T; Naoyuki, K; Shin, F; Takanori, U; Tatsuo, H; Tetsuya, Y; Toshikazu, H; Toshitaka, N; Ueda, T; Yamamoto, T; Yamanaka, H; Yuji, M	3
Bardin, T; Ottaviani, S; Richette, P	1
Chohan, S	1
Al-Geizawi, S; Doares, W; Farney, A; Kaczmorski, S; Rogers, J; Stratta, R; Winfrey, S	1
Kriegsmann, J; Lange, U; Müller-Ladner, U; Panzner, I; Tausche, AK	1
Adenwalla, HN; O'Connor, CR	1
Becker, MA; Chefo, S; Chohan, S; Jackson, RL; MacDonald, PA	1
Schmidt, BM; Wagner, AD	1
Becker, MA; Gunawardhana, L; Hunt, B; MacDonald, PA	1
Das, P; Suresh, E	1
Chefo, S; Jackson, RL; MacDonald, PA; Wells, AF	1
Jutkowitz, E; Meltzer, M; Pizzi, LT	1
Beedkar, SD; Chobe, SS; Dawane, BS; Khobragade, CN; Yemul, OS	1
Abeles, AM	1
Hunt, B; Jackson, RL; MacDonald, PA	1
Duh, PD; Warnez, PM	1
Asmahan, MI; Hilmi, BA; Rosman, A	1
Richette, P	1
André, B; Bouquegneau, A; Delanaye, P; Dubois, BE	1
Chohan, S; Dabholkar, A; Hunt, B; Jackson, R; White, WB	1
Doghramji, PP; Mandell, BF; Pope, RS	1
Carey, JJ; Conway, R; Coughlan, RJ	1
Butani, L; Calogiuri, G; Di Leo, E; Ferrannini, A; Foti, C; Nettis, E	1
Herrero-Beites, AM; Perez-Ruiz, F	1
Keenan, RT	1
Lopez-Olivo, MA; Suarez-Almazor, ME; Tayar, JH	1
Chen, S; Cheng, Q; Li, Q; Liu, L; Luo, T; Lv, Q; Mei, M; Yang, S; Ye, P; Zhang, W	1
Chefo, S; Gunawardhana, L; MacDonald, PA; Whelton, A	1
Bomalaski, JS; Clark, MA	1
Hoshide, S; Kamatani, N; Kobayashi, H; Komoriya, K; Kubo, J; Nakachi, T; Takeda, K; Tsuchimoto, M; Yamanaka, H	1
Becker, MA; Eustace, D; Joseph-Ridge, N; MacDonald, PA; Palo, WA; Schumacher, HR; Vernillet, L; Wortmann, RL	1
Schumacher, HR	1
Choy, G	1
Tomlinson, B	1
Becker, MA; Eustace, D; Joseph-Ridge, N; MacDonald, PA; Palo, WA; Schumacher, HR; Streit, J; Wortmann, RL	1
Moreland, LW	1
Lustberg, ME	1
Gelber, AC	1
Murphy, G; Pohar, S	1
Ziegler, R	1
Bruce, SP	1
Gomberg, R	1
Hershfield, MS; Sundy, JS	1
Abeles, AM; Pillinger, MH; Rosenthal, P	1
Okamoto, K	1
Higashino, K; Hiroishi, K; Moriwaki, Y; Nasako, Y; Takahashi, S; Yamakita, J; Yamamoto, T	1
Couch, RC; Griffin, TB; Hasegawa, M; Horiuchi, H; Komoriya, K; Kondo, S; Osada, Y	1
Iwamoto, Y; Iwatani, M; Kamatani, N; Wasada, T	1
Fox, IH; Lightfoot, RW; Ridolfo, AS; Wortmann, RL	1
Molina, J	1

Reviews

52 review(s) available for thiazoles and Gout

Article	Year
A systematic review and meta-analysis on the safety and efficacy of febuxostat versus allopurinol in chronic gout. Seminars in arthritis and rheumatism, 2013, Volume: 43, Issue:3 Topics: Allopurinol; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Thiazoles; Treatment Outcome; Uric Acid	2013
Safety profile of anti-gout agents: an update. Current opinion in rheumatology, 2014, Volume: 26, Issue:2 Topics: Allopurinol; Colchicine; Drug Interactions; Febuxostat; Gout; Gout Suppressants; HLA-B Antigens; Humans; Interleukin-1; Polyethylene Glycols; Risk Factors; Safety; Thiazoles; Urate Oxidase	2014
Therapeutic approaches to chronic hyperuricemia and gout. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2014, Volume: 21, Issue:4 Topics: Allopurinol; Cardiovascular Diseases; Chronic Disease; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Kidney Diseases; Life Style; Patient Education as Topic; Thiazoles; Xanthine Oxidase	2014
Long-term management of gout: nonpharmacologic and pharmacologic therapies. Rheumatic diseases clinics of North America, 2014, Volume: 40, Issue:2 Topics: Allopurinol; Benzbromarone; Chronic Disease; Febuxostat; Feeding Behavior; Gout; Gout Suppressants; Humans; Hyperuricemia; Polyethylene Glycols; Risk Reduction Behavior; Thiazoles; Urate Oxidase; Uricosuric Agents	2014
Emerging therapies for gout. Rheumatic diseases clinics of North America, 2014, Volume: 40, Issue:2 Topics: Acetamides; Adrenocorticotropic Hormone; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Benzodiazepines; Febuxostat; Gout; Gout Suppressants; Humans; Imino Furanoses; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Melanocortins; Phenylacetates; Polyethylene Glycols; Pyrimidinones; Recombinant Fusion Proteins; Thiazoles; Thioglycolates; Triazoles; Urate Oxidase; Uricosuric Agents	2014
Clinical inquiry: Which prophylactic therapies best prevent gout attacks? The Journal of family practice, 2014, Volume: 63, Issue:4 Topics: Allopurinol; Colchicine; Evidence-Based Medicine; Febuxostat; Gout; Gout Suppressants; Humans; Polyethylene Glycols; Quality of Life; Thiazoles; Urate Oxidase	2014
Allopurinol for chronic gout. The Cochrane database of systematic reviews, 2014, Oct-14, Issue:10 Topics: Allopurinol; Benzbromarone; Chronic Disease; Colchicine; Febuxostat; Gout; Gout Suppressants; Humans; Probenecid; Randomized Controlled Trials as Topic; Thiazoles; Uric Acid	2014
Advances in pharmacotherapy for the treatment of gout. Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:4 Topics: Adrenal Cortex Hormones; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzbromarone; Clinical Trials, Phase III as Topic; Colchicine; Febuxostat; Gout; Gout Suppressants; Humans; Polyethylene Glycols; Probenecid; Thiazoles; Urate Oxidase; Uric Acid	2015
Febuxostat for the treatment of gout. Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:3 Topics: Febuxostat; Gout; Gout Suppressants; Humans; Thiazoles; Xanthine Oxidase	2015
[A model-based meta-analysis to compare urate-lowering response rate of febuxostat and allopurinol in gout patient]. Yao xue xue bao = Acta pharmaceutica Sinica, 2014, Volume: 49, Issue:12 Topics: Allopurinol; Febuxostat; Gout; Gout Suppressants; Humans; Thiazoles; Uric Acid	2014
Febuxostat. Drugs, 2008, Volume: 68, Issue:13 Topics: Administration, Oral; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Molecular Structure; Randomized Controlled Trials as Topic; Thiazoles; Treatment Outcome; Uric Acid	2008
Febuxostat: a novel non-purine selective inhibitor of xanthine oxidase for the treatment of hyperuricemia in gout. Recent patents on inflammation & allergy drug discovery, 2007, Volume: 1, Issue:1 Topics: Animals; Clinical Trials as Topic; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Patents as Topic; Thiazoles; Xanthine Oxidase	2007
Update on emerging urate-lowering therapies. Current opinion in rheumatology, 2009, Volume: 21, Issue:2 Topics: Allopurinol; Drug Discovery; Enzyme Inhibitors; Febuxostat; Gout; Gout Suppressants; Humans; Polyethylene Glycols; Thiazoles; United States; Urate Oxidase; Uric Acid; Uricosuric Agents; Xanthine Oxidase	2009
Febuxostat: a new treatment for hyperuricaemia in gout. Rheumatology (Oxford, England), 2009, Volume: 48 Suppl 2 Topics: Allopurinol; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Randomized Controlled Trials as Topic; Thiazoles	2009
Febuxostat (Uloric) for chronic treatment of gout. The Medical letter on drugs and therapeutics, 2009, May-18, Volume: 51, Issue:1312 Topics: Chronic Disease; Clinical Trials as Topic; Drug Interactions; Febuxostat; Gout; Gout Suppressants; Humans; Thiazoles	2009
Febuxostat: a new agent for lowering serum urate. Drugs of today (Barcelona, Spain : 1998), 2009, Volume: 45, Issue:4 Topics: Animals; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Interactions; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Kidney Diseases; Liver Diseases; Thiazoles	2009
Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal. Health technology assessment (Winchester, England), 2009, Volume: 13 Suppl 3 Topics: Allopurinol; Cost-Benefit Analysis; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Randomized Controlled Trials as Topic; Thiazoles	2009
Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout. Clinical therapeutics, 2009, Volume: 31, Issue:11 Topics: Allopurinol; Biotransformation; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Febuxostat; Gout; Gout Suppressants; Half-Life; Humans; Hyperuricemia; Thiazoles; Tissue Distribution; Uric Acid; Xanthine Dehydrogenase; Xanthine Oxidase	2009
Progress in the pharmacotherapy of gout. Current opinion in rheumatology, 2010, Volume: 22, Issue:2 Topics: Allopurinol; Clinical Trials as Topic; Colchicine; Drug Therapy, Combination; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Recombinant Fusion Proteins; Thiazoles; Uricosuric Agents	2010
Management of hyperuricemia in gout: focus on febuxostat. Clinical interventions in aging, 2010, Feb-02, Volume: 5 Topics: Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Thiazoles; Treatment Outcome; Xanthine Oxidase	2010
International position paper on febuxostat. Clinical rheumatology, 2010, Volume: 29, Issue:8 Topics: Febuxostat; Gout; Gout Suppressants; Humans; International Cooperation; Thiazoles; Treatment Outcome; Xanthine Oxidase	2010
New agents for the treatment of gout and hyperuricemia: febuxostat, puricase, and beyond. Current rheumatology reports, 2010, Volume: 12, Issue:2 Topics: Acute Disease; Chronic Disease; Colchicine; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Polyethylene Glycols; Thiazoles; Urate Oxidase	2010
Urate-lowering therapy for gout: focus on febuxostat. Pharmacotherapy, 2010, Volume: 30, Issue:6 Topics: Clinical Trials as Topic; Drug Interactions; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Models, Biological; Thiazoles; Xanthine Oxidase	2010
[The clinical picture of gout is changing]. Duodecim; laaketieteellinen aikakauskirja, 2010, Volume: 126, Issue:12 Topics: Adrenal Cortex Hormones; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Diet; Febuxostat; Gout; Gout Suppressants; Humans; Probenecid; Risk Factors; Thiazoles; Uricosuric Agents	2010
Gout therapeutics: new drugs for an old disease. Lancet (London, England), 2011, Jan-08, Volume: 377, Issue:9760 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Clinical Trials as Topic; Drug Administration Schedule; Drug Approval; Enzyme Inhibitors; Europe; Febuxostat; Gout; Gout Suppressants; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Polyethylene Glycols; Randomized Controlled Trials as Topic; Recombinant Fusion Proteins; Thiazoles; United States; United States Food and Drug Administration; Urate Oxidase; Uric Acid; Uricosuric Agents; Xanthine Oxidase	2011
Advances in gout: some answers, more questions. Arthritis research & therapy, 2010, Volume: 12, Issue:5 Topics: Allopurinol; Clinical Trials as Topic; Febuxostat; Gout; Gout Suppressants; Humans; Thiazoles	2010
Crystal arthropathies: recognizing and treating "the gouch". Primary care, 2010, Volume: 37, Issue:4 Topics: Allopurinol; Antimetabolites; Chronic Disease; Colchicine; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Probenecid; Thiazoles; Uric Acid; Uricosuric Agents	2010
Managing gout: how is it different in patients with chronic kidney disease? Cleveland Clinic journal of medicine, 2010, Volume: 77, Issue:12 Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Comorbidity; Disease Progression; Febuxostat; Gout; Gout Suppressants; Humans; Kidney Failure, Chronic; Risk Factors; Thiazoles	2010
Febuxostat for the management of hyperuricaemia in patients with gout: a NICE single technology appraisal. PharmacoEconomics, 2011, Volume: 29, Issue:2 Topics: Biomedical Technology; Clinical Trials as Topic; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Thiazoles	2011
Febuxostat for treatment of chronic gout. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011, Mar-01, Volume: 68, Issue:5 Topics: Allopurinol; Animals; Chronic Disease; Clinical Trials as Topic; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Thiazoles; Xanthine Oxidase	2011
[Treatment of gout]. La Revue de medecine interne, 2011, Volume: 32, Issue:12 Topics: Adrenal Cortex Hormones; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Thiazoles; Uric Acid; Uricosuric Agents	2011
Managing your patient with gout: a review of treatment options. Postgraduate medicine, 2011, Volume: 123, Issue:3 Topics: Allopurinol; Anti-Inflammatory Agents; Colchicine; Diet; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Life Style; Patient Education as Topic; Quality of Life; Risk Factors; Thiazoles	2011
[Febuxostat]. Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:23 Topics: Allopurinol; Enzyme Activation; Febuxostat; Gout; Gout Suppressants; Humans; Randomized Controlled Trials as Topic; Thiazoles; Uric Acid; Xanthine Oxidase	2011
A new standard of care? Studies on febuxostat in the management of hyperuricemia with and without gout. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2011, Volume: 17, Issue:4 Suppl 2 Topics: Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Primary Health Care; Thiazoles; Treatment Outcome; Uric Acid; Xanthine Oxidase	2011
[New therapeutic options for gout]. Presse medicale (Paris, France : 1983), 2011, Volume: 40, Issue:9 Pt 1 Topics: Allopurinol; Controlled Clinical Trials as Topic; Drug Approval; Drugs, Investigational; Febuxostat; Gout; Gout Suppressants; Humans; Interleukin-1beta; Organic Anion Transporters; Polyethylene Glycols; Recombinant Proteins; Thiazoles; Urate Oxidase	2011
[Gout - regardless of therapeutic options a "forgotten" disease]. Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:33 Topics: Allopurinol; Arthritis, Gouty; Benzbromarone; Combined Modality Therapy; Cytokines; Europe; Febuxostat; Gout; Gout Suppressants; Guideline Adherence; Humans; Inflammasomes; Interleukin-1; Long-Term Care; Probenecid; Signal Transduction; Thiazoles; Uric Acid	2011
[Hyperuricemia, gout, pseudogout and concomitant diseases]. Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:48 Topics: Allopurinol; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Chondrocalcinosis; Comorbidity; Diabetes Mellitus, Type 2; Febuxostat; Gout; Gout Suppressants; Guideline Adherence; Humans; Hypertrophy, Left Ventricular; Hyperuricemia; Interleukin 1 Receptor Antagonist Protein; Kidney Failure, Chronic; Thiazoles; Xanthine Oxidase	2011
Recent advances in management of gout. QJM : monthly journal of the Association of Physicians, 2012, Volume: 105, Issue:5 Topics: Adrenal Cortex Hormones; Alcohol Drinking; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Ascorbic Acid; Colchicine; Comorbidity; Cryotherapy; Diet; Dose-Response Relationship, Drug; Febuxostat; Fructose; Gout; Gout Suppressants; Humans; Interleukin 1 Receptor Antagonist Protein; Polyethylene Glycols; Purines; Receptors, Interleukin-1; Recombinant Fusion Proteins; Thiazoles; Urate Oxidase; Uric Acid; Uricosuric Agents; Vitamins; Xanthine Oxidase	2012
[Pharmacological sheet. Febuxostat, oral (Adenuric)]. Journal de pharmacie de Belgique, 2012, Issue:1 Topics: Contraindications; Drug Interactions; Febuxostat; Gout; Gout Suppressants; Humans; Thiazoles	2012
[Gout: an overview of available urate lowering therapies]. Annales pharmaceutiques francaises, 2012, Volume: 70, Issue:3 Topics: Allopurinol; Enzyme Inhibitors; Febuxostat; Gout; Gout Suppressants; Guidelines as Topic; Humans; Organ Transplantation; Polyethylene Glycols; Thiazoles; Urate Oxidase; Uric Acid; Uricosuric Agents; Xanthine Oxidase	2012
Evaluation and treatment of gout as a chronic disease. Advances in therapy, 2012, Volume: 29, Issue:11 Topics: Arthritis, Gouty; Chronic Disease; Disease Progression; Evaluation Studies as Topic; Febuxostat; Female; Follow-Up Studies; Gout; Gout Suppressants; Humans; Male; Pain Measurement; Polyethylene Glycols; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Thiazoles; Treatment Outcome; Urate Oxidase; Uric Acid	2012
Safety of urate-lowering therapies: managing the risks to gain the benefits. Rheumatic diseases clinics of North America, 2012, Volume: 38, Issue:4 Topics: Allopurinol; Comorbidity; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Risk Factors; Thiazoles; Uric Acid	2012
Febuxostat for treating chronic gout. The Cochrane database of systematic reviews, 2012, Nov-14, Volume: 11 Topics: Allopurinol; Chronic Disease; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Randomized Controlled Trials as Topic; Thiazoles	2012
Efficacy and tolerability of febuxostat in hyperuricemic patients with or without gout: a systematic review and meta-analysis. Clinical therapeutics, 2013, Volume: 35, Issue:2 Topics: Allopurinol; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Randomized Controlled Trials as Topic; Thiazoles; Uric Acid	2013
Serum uric acid-lowering therapies: where are we heading in management of hyperuricemia and the potential role of uricase. Current rheumatology reports, 2004, Volume: 6, Issue:3 Topics: Allopurinol; Amlodipine; Clinical Trials as Topic; Enzyme Inhibitors; Febuxostat; Gout; Humans; Hyperuricemia; Losartan; Pyrazoles; Thiazoles; Treatment Outcome; Urate Oxidase; Uric Acid; Xanthine Oxidase	2004
Febuxostat: a non-purine, selective inhibitor of xanthine oxidase for the management of hyperuricaemia in patients with gout. Expert opinion on investigational drugs, 2005, Volume: 14, Issue:7 Topics: Disease Management; Enzyme Inhibitors; Febuxostat; Gout; Humans; Hyperuricemia; Thiazoles; Xanthine Oxidase	2005
An update on the treatment options for gout and calcium pyrophosphate deposition. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:14 Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Allopurinol; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Chondrocalcinosis; Colchicine; Drug Combinations; Enzyme Inhibitors; Febuxostat; Gout; Gout Suppressants; Humans; Multicenter Studies as Topic; Probenecid; Randomized Controlled Trials as Topic; Thiazoles; Uric Acid; Uricosuric Agents; Xanthine Oxidase	2005
Febuxostat: a selective xanthine oxidase inhibitor for the treatment of hyperuricemia and gout. The Annals of pharmacotherapy, 2006, Volume: 40, Issue:12 Topics: Febuxostat; Gout; Humans; Hyperuricemia; Thiazoles; Xanthine Oxidase	2006
Uricase and other novel agents for the management of patients with treatment-failure gout. Current rheumatology reports, 2007, Volume: 9, Issue:3 Topics: Allopurinol; Febuxostat; Gout; Gout Suppressants; Humans; Randomized Controlled Trials as Topic; Recombinant Proteins; Thiazoles; Treatment Failure; Urate Oxidase; Uric Acid	2007
Hyperuricemia and gout: new insights into pathogenesis and treatment. Bulletin of the NYU hospital for joint diseases, 2007, Volume: 65, Issue:3 Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Interleukin 1 Receptor Antagonist Protein; Thiazoles; Urate Oxidase; Uric Acid	2007
[Inhibitors of xanthine oxidoreductase]. Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:4 Topics: Allopurinol; Drug Design; Enzyme Inhibitors; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Nitriles; Pyrazoles; Pyridines; Thiazoles; Xanthine Dehydrogenase	2008
[Insulin sensitizer and urate metabolism]. Nihon rinsho. Japanese journal of clinical medicine, 2000, Volume: 58, Issue:2 Topics: Chromans; Diabetes Mellitus, Type 2; Female; Glucose; Gout; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Insulin Resistance; Male; Obesity; Syndrome; Thiazoles; Thiazolidinediones; Troglitazone; Uric Acid	2000

Trials

30 trial(s) available for thiazoles and Gout

Article	Year
Evaluation of the Relationship Between Serum Urate Levels, Clinical Manifestations of Gout, and Death From Cardiovascular Causes in Patients Receiving Febuxostat or Allopurinol in an Outcomes Trial. Arthritis & rheumatology (Hoboken, N.J.), 2022, Volume: 74, Issue:9 Topics: Allopurinol; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Thiazoles; Treatment Outcome; Uric Acid	2022
Effects of intensive urate lowering therapy with febuxostat in comparison with allopurinol on pulse wave velocity in patients with gout and increased cardiovascular risk: the FORWARD study. European heart journal. Cardiovascular pharmacotherapy, 2022, 05-05, Volume: 8, Issue:3 Topics: Adult; Allopurinol; Cardiovascular Diseases; Febuxostat; Gout; Gout Suppressants; Heart Disease Risk Factors; Humans; Pulse Wave Analysis; Risk Factors; Thiazoles; Treatment Outcome; Uric Acid	2022
Diabetes and gout: efficacy and safety of febuxostat and allopurinol. Diabetes, obesity & metabolism, 2013, Volume: 15, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Body Mass Index; Cohort Studies; Comorbidity; Diabetes Complications; Dose-Response Relationship, Drug; Enzyme Inhibitors; Febuxostat; Female; Gout; Gout Suppressants; Humans; Intention to Treat Analysis; Kidney; Lost to Follow-Up; Male; Middle Aged; Obesity; Patient Dropouts; Renal Insufficiency; Thiazoles; Xanthine Oxidase; Young Adult	2013
As compared to allopurinol, urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout. Rheumatology international, 2014, Volume: 34, Issue:1 Topics: Aged; Allopurinol; Biomarkers; Chronic Disease; Enzyme Inhibitors; Febuxostat; Germany; Glomerular Filtration Rate; Gout; Gout Suppressants; Humans; Inflammation Mediators; Kidney; Male; Middle Aged; Oxidative Stress; Prospective Studies; Pulse Wave Analysis; Severity of Illness Index; Thiazoles; Time Factors; Treatment Outcome; Uric Acid; Vascular Stiffness; Xanthine Oxidase	2014
An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia. International journal of rheumatic diseases, 2014, Volume: 17, Issue:6 Topics: Adult; Allopurinol; Biomarkers; China; Double-Blind Method; Enzyme Inhibitors; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Remission Induction; Thiazoles; Time Factors; Treatment Outcome; Uric Acid; Xanthine Oxidase	2014
Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia. Rheumatology (Oxford, England), 2014, Volume: 53, Issue:12 Topics: Adult; Aged; Colchicine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Thiazoles; Thioglycolates; Triazoles; Uric Acid	2014
Four-week effects of allopurinol and febuxostat treatments on blood pressure and serum creatinine level in gouty men. Journal of Korean medical science, 2014, Volume: 29, Issue:8 Topics: Allopurinol; Biomarkers; Blood Pressure; Creatinine; Dose-Response Relationship, Drug; Febuxostat; Gout; Gout Suppressants; Humans; Hypertension, Renal; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Thiazoles; Treatment Outcome	2014
Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinol. International journal of clinical oncology, 2016, Volume: 21, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Neoplasms; Thiazoles; Tumor Lysis Syndrome; Uric Acid; Xanthine Oxidase; Young Adult	2016
Determinants of the clinical outcomes of gout during the first year of urate-lowering therapy. Nucleosides, nucleotides & nucleic acids, 2008, Volume: 27, Issue:6 Topics: Allopurinol; Febuxostat; Gout; Gout Suppressants; Humans; Linear Models; Multivariate Analysis; Odds Ratio; Thiazoles; Time Factors; Treatment Outcome	2008
Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial. Arthritis and rheumatism, 2008, Nov-15, Volume: 59, Issue:11 Topics: Adult; Aged; Allopurinol; Creatinine; Dose-Response Relationship, Drug; Double-Blind Method; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Thiazoles; Treatment Outcome; Uric Acid	2008
Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study. Rheumatology (Oxford, England), 2009, Volume: 48, Issue:2 Topics: Adult; Aged; Biomarkers; Clinical Trials, Phase II as Topic; Febuxostat; Female; Follow-Up Studies; Gout; Gout Suppressants; Humans; Joints; Male; Middle Aged; Thiazoles; Treatment Outcome; Uric Acid; Young Adult	2009
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial. Arthritis research & therapy, 2010, Volume: 12, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Comorbidity; Dose-Response Relationship, Drug; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hyperlipidemias; Hypertension; Hyperuricemia; Kidney Diseases; Male; Middle Aged; Obesity; Thiazoles; Treatment Outcome; United States; Uric Acid; Young Adult	2010
Renal function in gout: long-term treatment effects of febuxostat. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2011, Volume: 17, Issue:1 Topics: Adult; Aged; Double-Blind Method; Febuxostat; Female; Glomerular Filtration Rate; Gout; Gout Suppressants; Humans; Hyperuricemia; Kidney; Male; Middle Aged; Thiazoles; Young Adult	2011
Effect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trials. Clinical therapeutics, 2010, Volume: 32, Issue:14 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Double-Blind Method; Drug Administration Schedule; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Thiazoles; Treatment Outcome; Uric Acid; Young Adult	2010
Febuxostat in gout: serum urate response in uric acid overproducers and underexcretors. The Journal of rheumatology, 2011, Volume: 38, Issue:7 Topics: Adult; Aged; Double-Blind Method; Febuxostat; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Thiazoles; Treatment Outcome; Uric Acid; Xanthine Oxidase	2011
An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: p Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2011, Volume: 17, Issue:4 Suppl 2 Topics: Administration, Oral; Allopurinol; Dose-Response Relationship, Drug; Double-Blind Method; Febuxostat; Female; Follow-Up Studies; Gout; Gout Suppressants; Humans; Hyperuricemia; Japan; Male; Middle Aged; Thiazoles; Treatment Outcome; Uric Acid; Xanthine Oxidase	2011
Placebo-controlled, double-blind study of the non-purine-selective xanthine oxidase inhibitor Febuxostat (TMX-67) in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2011, Volume: 17, Issue:4 Suppl 2 Topics: Adult; Central Nervous System Diseases; Dental Enamel; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Febuxostat; Female; Follow-Up Studies; Gout; Gout Suppressants; Humans; Japan; Kidney Diseases, Cystic; Male; Middle Aged; Thiazoles; Treatment Outcome; Uric Acid; Xanthine Oxidase	2011
Placebo-controlled double-blind dose-response study of the non-purine-selective xanthine oxidase inhibitor febuxostat (TMX-67) in patients with hyperuricemia (including gout patients) in japan: late phase 2 clinical study. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2011, Volume: 17, Issue:4 Suppl 2 Topics: Administration, Oral; Dose-Response Relationship, Drug; Double-Blind Method; Febuxostat; Female; Follow-Up Studies; Gout; Gout Suppressants; Humans; Hyperuricemia; Japan; Male; Middle Aged; Thiazoles; Treatment Outcome; Uric Acid; Xanthine Oxidase	2011
An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phas Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2011, Volume: 17, Issue:4 Suppl 2 Topics: Administration, Oral; Allopurinol; Dose-Response Relationship, Drug; Double-Blind Method; Febuxostat; Female; Follow-Up Studies; Gout; Gout Suppressants; Humans; Hyperuricemia; Japan; Male; Middle Aged; Thiazoles; Time Factors; Treatment Outcome; Uric Acid; Xanthine Oxidase	2011
Multicenter, open-label study of long-term administration of febuxostat (TMX-67) in Japanese patients with hyperuricemia including gout. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2011, Volume: 17, Issue:4 Suppl 2 Topics: Administration, Oral; Adult; Dose-Response Relationship, Drug; Febuxostat; Female; Follow-Up Studies; Gout; Gout Suppressants; Humans; Hyperuricemia; Japan; Male; Middle Aged; Thiazoles; Time Factors; Treatment Outcome; Uric Acid; Xanthine Oxidase	2011
Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol. Arthritis care & research, 2012, Volume: 64, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Cardiovascular Diseases; Comorbidity; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hyperuricemia; Illinois; Male; Metabolic Diseases; Middle Aged; Obesity; Retrospective Studies; Sex Factors; Thiazoles; Treatment Outcome; Uric Acid; Young Adult	2012
Treating hyperuricemia of gout: safety and efficacy of febuxostat and allopurinol in older versus younger subjects. Nucleosides, nucleotides & nucleic acids, 2011, Volume: 30, Issue:12 Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Allopurinol; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Liver Function Tests; Male; Middle Aged; Thiazoles; Treatment Outcome; Uric Acid	2011
African American patients with gout: efficacy and safety of febuxostat vs allopurinol. BMC musculoskeletal disorders, 2012, Feb-09, Volume: 13 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Black or African American; Comorbidity; Febuxostat; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Thiazoles; White People; Young Adult	2012
The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age. BMC geriatrics, 2012, Mar-21, Volume: 12 Topics: Aged; Aged, 80 and over; Biomarkers; Cohort Studies; Double-Blind Method; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Thiazoles; Treatment Outcome; Uric Acid; Xanthine Oxidase	2012
Cardiovascular safety of febuxostat and allopurinol in patients with gout and cardiovascular comorbidities. American heart journal, 2012, Volume: 164, Issue:1 Topics: Allopurinol; Cardiovascular Diseases; Double-Blind Method; Febuxostat; Gout; Gout Suppressants; Humans; Prospective Studies; Thiazoles	2012
Preservation of renal function during gout treatment with febuxostat: a quantitative study. Postgraduate medicine, 2013, Volume: 125, Issue:1 Topics: Adult; Aged; Allopurinol; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hyperuricemia; Kidney; Kidney Function Tests; Male; Middle Aged; Thiazoles; Treatment Outcome; Uric Acid	2013
Pharmacokinetics and pharmacodynamics of febuxostat (TMX-67), a non-purine selective inhibitor of xanthine oxidase/xanthine dehydrogenase (NPSIXO) in patients with gout and/or hyperuricemia. Nucleosides, nucleotides & nucleic acids, 2004, Volume: 23, Issue:8-9 Topics: Area Under Curve; Enzyme Inhibitors; Febuxostat; Gout; Humans; Hyperuricemia; Male; Oxygen; Thiazoles; Time Factors; Xanthine Dehydrogenase; Xanthine Oxidase	2004
Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout. Arthritis and rheumatism, 2005, Volume: 52, Issue:3 Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Febuxostat; Female; Gout; Humans; Hyperuricemia; Male; Middle Aged; Thiazoles; Treatment Outcome; Uric Acid; Xanthine Oxidase	2005
Febuxostat compared with allopurinol in patients with hyperuricemia and gout. The New England journal of medicine, 2005, Dec-08, Volume: 353, Issue:23 Topics: Allopurinol; Double-Blind Method; Enzyme Inhibitors; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Thiazoles; Uric Acid; Xanthine Oxidase	2005
Antihyperuricemic properties of amflutizole in gout. The Journal of rheumatology, 1985, Volume: 12, Issue:3 Topics: Adult; Aged; Arthritis; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Tolerance; Female; Gout; Gout Suppressants; Humans; Kidney; Male; Middle Aged; Random Allocation; Thiazoles; Uric Acid; Xanthine Oxidase	1985

Other Studies

63 other study(ies) available for thiazoles and Gout

Article	Year
Hypersensitivity to Febuxostat in a Patient with a Previous Allopurinolinduced Steven-Johnson Syndrome: A Case Report of Treatment with a Slow Desensitization Protocol. Endocrine, metabolic & immune disorders drug targets, 2022, Volume: 22, Issue:8 Topics: Adult; Febuxostat; Gout; Gout Suppressants; Humans; Hypersensitivity; Male; Thiazoles	2022
Efficacy of febuxostat versus allopurinol and the predictors of achieving target serum urate in a cohort of Thai people with gout. Clinical rheumatology, 2021, Volume: 40, Issue:1 Topics: Allopurinol; Cohort Studies; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Retrospective Studies; Thailand; Thiazoles; Treatment Outcome; Uric Acid	2021
Cardiovascular Safety of Febuxostat. The New England journal of medicine, 2018, 10-18, Volume: 379, Issue:16 Topics: Cardiovascular System; Febuxostat; Gout; Humans; Thiazoles; Treatment Outcome; Uric Acid	2018
Cardiovascular Safety of Febuxostat. The New England journal of medicine, 2018, 10-18, Volume: 379, Issue:16 Topics: Cardiovascular System; Febuxostat; Gout; Humans; Thiazoles; Treatment Outcome; Uric Acid	2018
Cardiovascular Safety of Febuxostat. The New England journal of medicine, 2018, 10-18, Volume: 379, Issue:16 Topics: Cardiovascular System; Febuxostat; Gout; Humans; Thiazoles; Treatment Outcome; Uric Acid	2018
Cardiovascular Safety of Febuxostat. The New England journal of medicine, 2018, 10-18, Volume: 379, Issue:16 Topics: Cardiovascular System; Febuxostat; Gout; Humans; Thiazoles; Treatment Outcome; Uric Acid	2018
Italian Society of Rheumatology recommendations for the management of gout. Reumatismo, 2013, Mar-28, Volume: 65, Issue:1 Topics: Adrenal Cortex Hormones; Advisory Committees; Alcoholic Beverages; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Combined Modality Therapy; Dairy Products; Disease Management; Evidence-Based Medicine; Febuxostat; Female; Fructose; Gout; Humans; Italy; Male; Risk Factors; Smoking; Societies, Medical; Thiazoles; Uric Acid	2013
Cost-effectiveness of febuxostat in chronic gout. The European journal of health economics : HEPAC : health economics in prevention and care, 2014, Volume: 15, Issue:5 Topics: Cost-Benefit Analysis; Dose-Response Relationship, Drug; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Markov Chains; Models, Economic; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Reproducibility of Results; Thiazoles; Uric Acid	2014
Clinical and health care use characteristics of patients newly starting allopurinol, febuxostat, and colchicine for the treatment of gout. Arthritis care & research, 2013, Volume: 65, Issue:12 Topics: Allopurinol; Ambulatory Care; Colchicine; Comorbidity; Febuxostat; Female; Gout; Gout Suppressants; Hospitalization; Humans; Male; Middle Aged; Office Visits; Thiazoles	2013
Irregular gout. International journal of rheumatic diseases, 2014, Volume: 17, Issue:3 Topics: Chelating Agents; Comorbidity; Febuxostat; Gout; Gout Suppressants; Humans; Lead Poisoning; Male; Occupational Diseases; Occupational Exposure; Renal Insufficiency, Chronic; Thiazoles; Treatment Outcome; Young Adult	2014
CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts. The American journal of medicine, 2014, Volume: 127, Issue:1 Topics: Allopurinol; Comorbidity; Disease Management; Drug Administration Schedule; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Medication Adherence; Primary Health Care; Risk Factors; Severity of Illness Index; Thiazoles; United States; Uric Acid	2014
Rhabdomyolysis associated with initiation of febuxostat therapy for hyperuricaemia in a patient with chronic kidney disease. Journal of clinical pharmacy and therapeutics, 2014, Volume: 39, Issue:3 Topics: Aged; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Renal Insufficiency, Chronic; Rhabdomyolysis; Thiazoles	2014
Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative study. Arthritis research & therapy, 2014, Mar-29, Volume: 16, Issue:2 Topics: Aged; Allopurinol; Black or African American; Evaluation Studies as Topic; Febuxostat; Female; Focus Groups; Gout; Gout Suppressants; Health Knowledge, Attitudes, Practice; Humans; Male; Medication Adherence; Middle Aged; Thiazoles; Uric Acid	2014
Achieving serum urate goal: a comparative effectiveness study between allopurinol and febuxostat. Postgraduate medicine, 2014, Volume: 126, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Biomarkers; Comparative Effectiveness Research; Drug Administration Schedule; Febuxostat; Female; Follow-Up Studies; Gout; Gout Suppressants; Humans; Logistic Models; Male; Middle Aged; Retrospective Studies; Thiazoles; Treatment Outcome; Uric Acid; Young Adult	2014
Prevalence of treatment of hyperuricemic in patients admitted to the rheumatology ward and evaluation of compliance with the 2012 ACR Guidelines. Joint bone spine, 2014, Volume: 81, Issue:5 Topics: Aged; Allopurinol; Febuxostat; Female; Gout; Gout Suppressants; Guideline Adherence; Hospitalization; Humans; Hyperuricemia; Male; Prevalence; Thiazoles; Xanthine Oxidase	2014
Treat to target in gout by combining two modes of action. Rheumatology (Oxford, England), 2014, Volume: 53, Issue:12 Topics: Febuxostat; Female; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Thiazoles; Thioglycolates; Triazoles	2014
Prevention of comorbidity and acute attack of gout by uric acid lowering therapy. Journal of Korean medical science, 2014, Volume: 29, Issue:5 Topics: Adult; Allopurinol; Antimetabolites; Benzbromarone; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hypertension; Male; Middle Aged; Renal Insufficiency, Chronic; Retrospective Studies; Thiazoles; Uric Acid; Uricosuric Agents; Urolithiasis	2014
Efficacy and safety of febuxostat in elderly female patients. Clinical interventions in aging, 2014, Volume: 9 Topics: Aged; Comorbidity; Febuxostat; Female; Glomerular Filtration Rate; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Retrospective Studies; Thiazoles; Treatment Outcome	2014
Can febuxostat reduce triglyceride and cholesterol serum levels in gouty patients? Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2014, Volume: 20, Issue:7 Topics: Aged; Cholesterol; Febuxostat; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Thiazoles; Triglycerides	2014
Cost-effectiveness of allopurinol and febuxostat for the management of gout. Annals of internal medicine, 2014, Nov-04, Volume: 161, Issue:9 Topics: Allopurinol; Cost Savings; Cost-Benefit Analysis; Drug Therapy, Combination; Febuxostat; Gout; Gout Suppressants; Humans; Markov Chains; Models, Theoretical; Quality-Adjusted Life Years; Thiazoles	2014
Cost-effectiveness analysis of allopurinol versus febuxostat in chronic gout patients: a U.S. payer perspective. Journal of managed care & specialty pharmacy, 2015, Volume: 21, Issue:2 Topics: Allopurinol; Chronic Disease; Cost-Benefit Analysis; Febuxostat; Gout; Gout Suppressants; Humans; Markov Chains; Thiazoles; Uric Acid	2015
Characteristics and management of gout patients in Europe: data from a large cohort of patients. European review for medical and pharmacological sciences, 2015, Volume: 19, Issue:4 Topics: Adult; Allopurinol; Cohort Studies; Comorbidity; Cross-Sectional Studies; Europe; Febuxostat; Female; France; Gout; Gout Suppressants; Greece; Humans; Male; Middle Aged; Obesity; Patient Compliance; Thiazoles; Uric Acid	2015
Febuxostat for Asymptomatic Hyperuricemia in CKD. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2016, Volume: 67, Issue:6 Topics: Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Renal Insufficiency, Chronic; Thiazoles; Uric Acid; Xanthine Oxidase	2016
Febuxostat Renoprotection in CKD Patients With Asymptomatic Hyperuricemia. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2016, Volume: 67, Issue:6 Topics: Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Renal Insufficiency, Chronic; Thiazoles; Uric Acid	2016
In Reply to 'Febuxostat for Asymptomatic Hyperuricemia in CKD' and 'Febuxostat Renoprotection in CKD Patients With Asymptomatic Hyperuricemia'. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2016, Volume: 67, Issue:6 Topics: Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Renal Insufficiency, Chronic; Thiazoles; Uric Acid	2016
Febuxostat for Patients With Gout and Severe Chronic Kidney Disease: Which Is the Appropriate Dosage? Comment on the Article by Saag et al. Arthritis & rheumatology (Hoboken, N.J.), 2016, Volume: 68, Issue:10 Topics: Allopurinol; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Renal Insufficiency, Chronic; Thiazoles; Uric Acid	2016
Febuxostat: a viewpoint by H. Ralph Schumacher Jr and Lan X. Chen. Drugs, 2008, Volume: 68, Issue:13 Topics: Administration, Oral; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Thiazoles; Uric Acid	2008
Febuxostat : a viewpoint by Naomi Schlesinger. Drugs, 2008, Volume: 68, Issue:13 Topics: Administration, Oral; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Thiazoles; Uric Acid	2008
Febuxostat : a viewpoint by N. Lawrence Edwards. Drugs, 2008, Volume: 68, Issue:13 Topics: Administration, Oral; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Thiazoles; Uric Acid	2008
Gout management: let's get it right this time. Arthritis and rheumatism, 2008, Nov-15, Volume: 59, Issue:11 Topics: Administration, Oral; Allopurinol; Dose-Response Relationship, Drug; Drug Evaluation; Europe; Febuxostat; Gout; Gout Suppressants; Humans; Thiazoles; Uric Acid; Xanthine Oxidase	2008
Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout. The Journal of rheumatology, 2009, Volume: 36, Issue:6 Topics: Allopurinol; Febuxostat; Gout; Gout Suppressants; Hyperuricemia; Thiazoles; Treatment Outcome; Uric Acid	2009
New gout treatment approved. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2009, Apr-01, Volume: 66, Issue:7 Topics: Administration, Oral; Drug Approval; Drug Interactions; Febuxostat; Gout; Gout Suppressants; Humans; Thiazoles; United States; United States Food and Drug Administration; Uric Acid; Xanthine Oxidase	2009
Gout Study Group: update on hyperuricemia and gout. Joint bone spine, 2009, Volume: 76, Issue:4 Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Diet; Europe; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Life Style; Prednisone; Prevalence; Thiazoles; United States; Uric Acid	2009
Febuxostat: new drug. Hyperuricaemia: risk of gout attacks. Prescrire international, 2009, Volume: 18, Issue:100 Topics: Allopurinol; Drug Approval; Europe; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Randomized Controlled Trials as Topic; Thiazoles	2009
Febuxostat provides new gout treatment option. The Nurse practitioner, 2010, Volume: 35, Issue:3 Topics: Drug Interactions; Febuxostat; Gout; Gout Suppressants; Humans; Thiazoles	2010
Febuxostat for gout. Drug and therapeutics bulletin, 2010, Volume: 48, Issue:7 Topics: Aged; Drug Costs; Febuxostat; Female; Gout; Gout Suppressants; Humans; Male; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Thiazoles	2010
The current state of care in gout: Addressing the need for better understanding of an ancient disease. Journal of the American Academy of Nurse Practitioners, 2010, Volume: 22 Suppl 1 Topics: Acute Disease; Aged; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Arthritis, Rheumatoid; Chronic Disease; Colchicine; Comorbidity; Disease Progression; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Patient Education as Topic; Quality of Life; Risk Factors; Thiazoles; Uric Acid; Uricosuric Agents; Xanthine Oxidase	2010
[Therapy of acute gout attack. It need not always be NSAID]. MMW Fortschritte der Medizin, 2010, Nov-25, Volume: 152, Issue:47 Topics: Anti-Inflammatory Agents, Non-Steroidal; Ascorbic Acid; Febuxostat; Gout; Gout Suppressants; Humans; Thiazoles	2010
Treatment of gout. Internal medicine journal, 2011, Volume: 41, Issue:1a Topics: Aged; Allopurinol; Australia; Colchicine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Febuxostat; Glomerular Filtration Rate; Gout; Gout Suppressants; Humans; Kidney Diseases; Male; Patient Compliance; Practice Guidelines as Topic; Prednisolone; Renal Dialysis; Thiazoles; Uric Acid	2011
Febuxostat efficacy in allopurinol-resistant tophaceous gout. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2011, Volume: 17, Issue:4 Topics: Allopurinol; Dose-Response Relationship, Drug; Drug Resistance; Febuxostat; Female; Gout; Gout Suppressants; Humans; Thiazoles; Treatment Failure; Treatment Outcome; Uric Acid; Young Adult	2011
Safety and efficacy of febuxostat treatment in subjects with gout and severe allopurinol adverse reactions. The Journal of rheumatology, 2011, Volume: 38, Issue:9 Topics: Aged; Aged, 80 and over; Allopurinol; Drug Monitoring; Febuxostat; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Thiazoles; Uric Acid	2011
Gout and transplantation: new treatment option-same old drug interaction. Transplantation, 2011, Aug-15, Volume: 92, Issue:3 Topics: Aged; Azathioprine; Drug Interactions; Febuxostat; Gout; Gout Suppressants; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Thiazoles	2011
Catastrophic axial gout causing paraplegia in a patient with glycogen storage disease. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2011, Volume: 17, Issue:7 Topics: Adult; Catastrophic Illness; Drug Therapy, Combination; Febuxostat; Glycogen Storage Disease Type I; Gout; Gout Suppressants; Humans; Magnetic Resonance Imaging; Male; Obesity, Morbid; Paraplegia; Prednisone; Probenecid; Radiography; Synovial Fluid; Thiazoles; Uric Acid	2011
Can racial disparities in optimal gout treatment be reduced? Evidence from a randomized trial. BMC medicine, 2012, Feb-09, Volume: 10 Topics: Allopurinol; Black or African American; Female; Gout; Gout Suppressants; Humans; Male; Thiazoles	2012
Payer decision-making with limited comparative and cost effectiveness data: the case of new pharmacological treatments for gout. Evidence-based medicine, 2012, Volume: 17, Issue:4 Topics: Allopurinol; Clinical Trials as Topic; Comparative Effectiveness Research; Cost-Benefit Analysis; Decision Making; Decision Trees; Febuxostat; Gout; Gout Suppressants; Humans; Thiazoles	2012
Novel thiazolo-pyrazolyl derivatives as xanthine oxidase inhibitors and free radical scavengers. International journal of biological macromolecules, 2012, May-01, Volume: 50, Issue:4 Topics: Allopurinol; Animals; Catalytic Domain; Drug Design; Enzyme Inhibitors; Free Radical Scavengers; Gout; Inhibitory Concentration 50; Models, Molecular; Pyrazoles; Rats; Thiazoles; Xanthine Oxidase	2012
Febuxostat hypersensitivity. The Journal of rheumatology, 2012, Volume: 39, Issue:3 Topics: Aged; Drug Hypersensitivity; Erythema; Fatigue; Febuxostat; Female; Gout; Gout Suppressants; Humans; Pruritus; Thiazoles; Withholding Treatment	2012
Use of newly available febuxostat in a case of chronic tophaceous gout contraindicated to allopurinol and probenecid. The Medical journal of Malaysia, 2012, Volume: 67, Issue:1 Topics: Allopurinol; Chronic Disease; Contraindications; Febuxostat; Gout; Gout Suppressants; Humans; Male; Middle Aged; Probenecid; Thiazoles	2012
[Medication of the month. Febuxostat (Adenuric)]. Revue medicale de Liege, 2012, Volume: 67, Issue:4 Topics: Clinical Trials as Topic; Febuxostat; Gout; Gout Suppressants; Humans; Thiazoles	2012
Casebook consults: improving outcomes in gout (multimedia activity). The American journal of medicine, 2012, Volume: 125, Issue:8 Topics: Adrenal Cortex Hormones; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Febuxostat; Gout; Gout Suppressants; Humans; Long-Term Care; Medication Adherence; Referral and Consultation; Thiazoles; Uric Acid	2012
Adherence to uric acid treatment guidelines in a rheumatology clinic. Clinical rheumatology, 2012, Volume: 31, Issue:12 Topics: Aged; Allopurinol; Febuxostat; Female; Gout; Gout Suppressants; Guideline Adherence; Humans; Male; Middle Aged; Probenecid; Retrospective Studies; Thiazoles; Treatment Outcome; Uric Acid	2012
Allopurinol hypersensitivity reactions: desensitization strategies and new therapeutic alternative molecules. Inflammation & allergy drug targets, 2013, Volume: 12, Issue:1 Topics: Allopurinol; Animals; Desensitization, Immunologic; Drug Hypersensitivity; Febuxostat; Gout; Humans; Hyperuricemia; Product Surveillance, Postmarketing; Recombinant Proteins; Skin; Thiazoles; Urate Oxidase	2013
Febuxostat (Teijin/Ipsen/TAP). Current opinion in investigational drugs (London, England : 2000), 2005, Volume: 6, Issue:11 Topics: Animals; Drug Evaluation, Preclinical; Enzyme Inhibitors; Febuxostat; Gout; Humans; Patents as Topic; Randomized Controlled Trials as Topic; Structure-Activity Relationship; Thiazoles; Xanthine Oxidase	2005
Febuxostat--treatment for hyperuricemia and gout? The New England journal of medicine, 2005, Dec-08, Volume: 353, Issue:23 Topics: Allopurinol; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Probenecid; Thiazoles; Uric Acid; Xanthine Oxidase	2005
Febuxostat versus allopurinol for gout. The New England journal of medicine, 2006, Apr-06, Volume: 354, Issue:14 Topics: Allopurinol; Enzyme Inhibitors; Febuxostat; Gout; Gout Suppressants; Humans; Thiazoles; Treatment Refusal; Xanthine Oxidase	2006
Febuxostat versus allopurinol for gout. The New England journal of medicine, 2006, Apr-06, Volume: 354, Issue:14 Topics: Allopurinol; Enzyme Inhibitors; Febuxostat; Gout; Gout Suppressants; Humans; Thiazoles; Treatment Refusal; Xanthine Oxidase	2006
Gout's not just for the gluttonous. The Johns Hopkins medical letter health after 50, 2006, Volume: 18, Issue:4 Topics: Allopurinol; Febuxostat; Female; Gout; Gout Suppressants; Humans; Male; Risk Factors; Sex Factors; Socioeconomic Factors; Thiazoles; Uric Acid	2006
Febuxostat for prevention of gout attacks. Issues in emerging health technologies, 2006, Issue:87 Topics: Allopurinol; Canada; Clinical Trials, Phase III as Topic; Gout; Gout Suppressants; Humans; Hyperuricemia; Randomized Controlled Trials as Topic; Thiazoles; Uric Acid; Xanthine Oxidase	2006
[Febuxostat versus allopurinol for hyperuricemia]. Medizinische Monatsschrift fur Pharmazeuten, 2006, Volume: 29, Issue:10 Topics: Allopurinol; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Thiazoles	2006
Possible case of allopurinol causing relapse of psychosis. Schizophrenia research, 2007, Volume: 93, Issue:1-3 Topics: Adult; Allopurinol; Antipsychotic Agents; Chronic Disease; Clozapine; Drug Therapy, Combination; Female; Gout; Gout Suppressants; Hallucinations; Humans; Piperazines; Psychoses, Substance-Induced; Recurrence; Schizophrenia, Paranoid; Thiazoles	2007
Determination of plasma purine nucleoside phosphorylase activity by high-performance liquid chromatography. Analytical biochemistry, 1995, May-01, Volume: 227, Issue:1 Topics: Adult; Aged; Asthma; Calibration; Chromatography, High Pressure Liquid; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hypoxanthine; Hypoxanthines; Inosine; Male; Middle Aged; Purine-Nucleoside Phosphorylase; Thiazoles; Uric Acid; Xanthine Oxidase	1995
Hypouricemic effect of allopurinol and the novel xanthine oxidase inhibitor TEI-6720 in chimpanzees. European journal of pharmacology, 1993, Dec-21, Volume: 250, Issue:3 Topics: Administration, Oral; Allopurinol; Animals; Dose-Response Relationship, Drug; Febuxostat; Female; Gout; Macaca mulatta; Male; Pan troglodytes; Thiazoles; Uric Acid; Xanthine; Xanthine Oxidase; Xanthines	1993
Fentiazac in acute gouty arthritis. Clinical therapeutics, 1985, Volume: 7, Issue:3 Topics: Acetates; Acute Disease; Adult; Aged; Anti-Inflammatory Agents; Arthritis; Female; Gout; Humans; Male; Middle Aged; Thiazoles	1985